Detalhe da pesquisa
1.
A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator.
Mov Disord
; 38(7): 1197-1208, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37195859
2.
A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls.
Mov Disord
; 38(5): 783-795, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36916660
3.
A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator.
Br J Clin Pharmacol
; 87(9): 3561-3573, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33576113
4.
A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
Mov Disord
; 35(9): 1667-1674, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32618053
5.
ß-Glucocerebrosidase Modulators Promote Dimerization of ß-Glucocerebrosidase and Reveal an Allosteric Binding Site.
J Am Chem Soc
; 140(18): 5914-5924, 2018 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676907
6.
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
Neurobiol Dis
; 106: 191-204, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28711409
7.
The Jury Is Still Out.
Mov Disord
; 37(3): 651, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040206
8.
The Sphingolipids Clearly Play a Role in Parkinson's Disease, but Nature Has Made it Complicated.
Mov Disord
; 37(10): 1985-1989, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087026
9.
A century-old debate on protein aggregation and neurodegeneration enters the clinic.
Nature
; 443(7113): 774-9, 2006 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17051203
10.
Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
Proc Natl Acad Sci U S A
; 106(12): 4635-40, 2009 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19261853
11.
Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice.
Mol Neurodegener
; 17(1): 54, 2022 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987691
12.
N-terminal deletion does not affect α-synuclein membrane binding, self-association and toxicity in human neuroblastoma cells, unlike yeast.
J Neurochem
; 119(2): 389-97, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21848810
13.
Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
J Clin Invest
; 118(2): 777-88, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18172548
14.
Genetics of Parkinson's disease and biochemical studies of implicated gene products.
Curr Opin Cell Biol
; 14(5): 653-60, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12231362
15.
Back to the future: the 'old-fashioned' way to new medications for neurodegeneration.
Nat Med
; 10 Suppl: S51-7, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15298008
16.
False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.
Sci Rep
; 11(1): 161, 2021 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420335
17.
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.
NPJ Parkinsons Dis
; 7(1): 65, 2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312398
18.
Design, Synthesis, and Biological Evaluation of a Series of Oxazolone Carboxamides as a Novel Class of Acid Ceramidase Inhibitors.
J Med Chem
; 63(24): 15821-15851, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290061
19.
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors.
J Med Chem
; 63(7): 3634-3664, 2020 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32176488
20.
Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.
Neuron
; 104(5): 869-884.e11, 2019 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648898